Global Live Attenuated Vaccine Market Professional Survey Report 2017

October 2017 | 101 pages | ID: G461C40F65EPEN
QYResearch

Abstracts

This report studies Live Attenuated Vaccine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Astellas Pharma (Japan)
• CSL Limited (Australia)
• Emergent BioSolutions (U.S.)
• GlaxoSmithKline (U.K.)
• Johnson & Johnson (U.S.)
• MedImmune (U.S.)
• Merck & Co (U.S.)
• Pfizer (U.S.)
• Sanofi Pasteur (France)
• Serum Institute of India Pvt (India)

By types, the market can be split into

• Pediatrics
• Adults

By Application, the market can be split into

• Hospital
• Medical Center
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Live Attenuated Vaccine Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF LIVE ATTENUATED VACCINE

1.1 Definition and Specifications of Live Attenuated Vaccine
  1.1.1 Definition of Live Attenuated Vaccine
  1.1.2 Specifications of Live Attenuated Vaccine
1.2 Classification of Live Attenuated Vaccine
  1.2.1 Pediatrics
  1.2.2 Adults
1.3 Applications of Live Attenuated Vaccine
  1.3.1 Hospital
  1.3.2 Medical Center
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF LIVE ATTENUATED VACCINE

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Live Attenuated Vaccine
2.3 Manufacturing Process Analysis of Live Attenuated Vaccine
2.4 Industry Chain Structure of Live Attenuated Vaccine

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF LIVE ATTENUATED VACCINE

3.1 Capacity and Commercial Production Date of Global Live Attenuated Vaccine Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Live Attenuated Vaccine Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Live Attenuated Vaccine Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Live Attenuated Vaccine Major Manufacturers in 2016

4 GLOBAL LIVE ATTENUATED VACCINE OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Live Attenuated Vaccine Capacity and Growth Rate Analysis
  4.2.2 2016 Live Attenuated Vaccine Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Live Attenuated Vaccine Sales and Growth Rate Analysis
  4.3.2 2016 Live Attenuated Vaccine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Live Attenuated Vaccine Sales Price
  4.4.2 2016 Live Attenuated Vaccine Sales Price Analysis (Company Segment)

5 LIVE ATTENUATED VACCINE REGIONAL MARKET ANALYSIS

5.1 North America Live Attenuated Vaccine Market Analysis
  5.1.1 North America Live Attenuated Vaccine Market Overview
  5.1.2 North America 2012-2017E Live Attenuated Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Live Attenuated Vaccine Sales Price Analysis
  5.1.4 North America 2016 Live Attenuated Vaccine Market Share Analysis
5.2 China Live Attenuated Vaccine Market Analysis
  5.2.1 China Live Attenuated Vaccine Market Overview
  5.2.2 China 2012-2017E Live Attenuated Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Live Attenuated Vaccine Sales Price Analysis
  5.2.4 China 2016 Live Attenuated Vaccine Market Share Analysis
5.3 Europe Live Attenuated Vaccine Market Analysis
  5.3.1 Europe Live Attenuated Vaccine Market Overview
  5.3.2 Europe 2012-2017E Live Attenuated Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Live Attenuated Vaccine Sales Price Analysis
  5.3.4 Europe 2016 Live Attenuated Vaccine Market Share Analysis
5.4 Southeast Asia Live Attenuated Vaccine Market Analysis
  5.4.1 Southeast Asia Live Attenuated Vaccine Market Overview
  5.4.2 Southeast Asia 2012-2017E Live Attenuated Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Live Attenuated Vaccine Sales Price Analysis
  5.4.4 Southeast Asia 2016 Live Attenuated Vaccine Market Share Analysis
5.5 Japan Live Attenuated Vaccine Market Analysis
  5.5.1 Japan Live Attenuated Vaccine Market Overview
  5.5.2 Japan 2012-2017E Live Attenuated Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Live Attenuated Vaccine Sales Price Analysis
  5.5.4 Japan 2016 Live Attenuated Vaccine Market Share Analysis
5.6 India Live Attenuated Vaccine Market Analysis
  5.6.1 India Live Attenuated Vaccine Market Overview
  5.6.2 India 2012-2017E Live Attenuated Vaccine Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Live Attenuated Vaccine Sales Price Analysis
  5.6.4 India 2016 Live Attenuated Vaccine Market Share Analysis

6 GLOBAL 2012-2017E LIVE ATTENUATED VACCINE SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Live Attenuated Vaccine Sales by Type
6.2 Different Types of Live Attenuated Vaccine Product Interview Price Analysis
6.3 Different Types of Live Attenuated Vaccine Product Driving Factors Analysis
  6.3.1 By End User of Live Attenuated Vaccine Growth Driving Factor Analysis
  6.3.2 By Disease Indication of Live Attenuated Vaccine Growth Driving Factor Analysis

7 GLOBAL 2012-2017E LIVE ATTENUATED VACCINE SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Live Attenuated Vaccine Consumption by Application
7.2 Different Application of Live Attenuated Vaccine Product Interview Price Analysis
7.3 Different Application of Live Attenuated Vaccine Product Driving Factors Analysis
  7.3.1 Hospital of Live Attenuated Vaccine Growth Driving Factor Analysis
  7.3.2 Medical Center of Live Attenuated Vaccine Growth Driving Factor Analysis
  7.3.3 Others of Live Attenuated Vaccine Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF LIVE ATTENUATED VACCINE

8.1 Astellas Pharma (Japan)
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Astellas Pharma (Japan) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Astellas Pharma (Japan) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.2 CSL Limited (Australia)
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 CSL Limited (Australia) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 CSL Limited (Australia) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.3 Emergent BioSolutions (U.S.)
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Emergent BioSolutions (U.S.) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Emergent BioSolutions (U.S.) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.4 GlaxoSmithKline (U.K.)
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 GlaxoSmithKline (U.K.) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 GlaxoSmithKline (U.K.) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.5 Johnson & Johnson (U.S.)
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Johnson & Johnson (U.S.) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Johnson & Johnson (U.S.) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.6 MedImmune (U.S.)
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 MedImmune (U.S.) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 MedImmune (U.S.) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.7 Merck & Co (U.S.)
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Merck & Co (U.S.) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Merck & Co (U.S.) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.8 Pfizer (U.S.)
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Pfizer (U.S.) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Pfizer (U.S.) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.9 Sanofi Pasteur (France)
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Sanofi Pasteur (France) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Sanofi Pasteur (France) 2016 Live Attenuated Vaccine Business Region Distribution Analysis
8.10 Serum Institute of India Pvt (India)
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Serum Institute of India Pvt (India) 2016 Live Attenuated Vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Serum Institute of India Pvt (India) 2016 Live Attenuated Vaccine Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF LIVE ATTENUATED VACCINE MARKET

9.1 Global Live Attenuated Vaccine Market Trend Analysis
  9.1.1 Global 2017-2022 Live Attenuated Vaccine Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Live Attenuated Vaccine Sales Price Forecast
9.2 Live Attenuated Vaccine Regional Market Trend
  9.2.1 North America 2017-2022 Live Attenuated Vaccine Consumption Forecast
  9.2.2 China 2017-2022 Live Attenuated Vaccine Consumption Forecast
  9.2.3 Europe 2017-2022 Live Attenuated Vaccine Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Live Attenuated Vaccine Consumption Forecast
  9.2.5 Japan 2017-2022 Live Attenuated Vaccine Consumption Forecast
  9.2.6 India 2017-2022 Live Attenuated Vaccine Consumption Forecast
9.3 Live Attenuated Vaccine Market Trend (Product Type)
9.4 Live Attenuated Vaccine Market Trend (Application)

10 LIVE ATTENUATED VACCINE MARKETING TYPE ANALYSIS

10.1 Live Attenuated Vaccine Regional Marketing Type Analysis
10.2 Live Attenuated Vaccine International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Live Attenuated Vaccine by Region
10.4 Live Attenuated Vaccine Supply Chain Analysis

11 CONSUMERS ANALYSIS OF LIVE ATTENUATED VACCINE

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL LIVE ATTENUATED VACCINE MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Live Attenuated Vaccine
Table Product Specifications of Live Attenuated Vaccine
Table Classification of Live Attenuated Vaccine
Figure Global Production Market Share of Live Attenuated Vaccine by Type in 2016
Figure Pediatrics Picture
Table Major Manufacturers of Pediatrics
Figure Adults Picture
Table Major Manufacturers of Adults
Table Applications of Live Attenuated Vaccine
Figure Global Consumption Volume Market Share of Live Attenuated Vaccine by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Medical Center Examples
Table Major Consumers in Medical Center
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Live Attenuated Vaccine by Regions
Figure North America Live Attenuated Vaccine Market Size (Million USD) (2012-2022)
Figure China Live Attenuated Vaccine Market Size (Million USD) (2012-2022)
Figure Europe Live Attenuated Vaccine Market Size (Million USD) (2012-2022)
Figure Southeast Asia Live Attenuated Vaccine Market Size (Million USD) (2012-2022)
Figure Japan Live Attenuated Vaccine Market Size (Million USD) (2012-2022)
Figure India Live Attenuated Vaccine Market Size (Million USD) (2012-2022)
Table Live Attenuated Vaccine Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Live Attenuated Vaccine in 2016
Figure Manufacturing Process Analysis of Live Attenuated Vaccine
Figure Industry Chain Structure of Live Attenuated Vaccine
Table Capacity and Commercial Production Date of Global Live Attenuated Vaccine Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Live Attenuated Vaccine Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Live Attenuated Vaccine Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Live Attenuated Vaccine Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Live Attenuated Vaccine 2012-2017
Figure Global 2012-2017E Live Attenuated Vaccine Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Live Attenuated Vaccine Market Size (Value) and Growth Rate
Table 2012-2017E Global Live Attenuated Vaccine Capacity and Growth Rate
Table 2016 Global Live Attenuated Vaccine Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Live Attenuated Vaccine Sales (K Pcs) and Growth Rate
Table 2016 Global Live Attenuated Vaccine Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Live Attenuated Vaccine Sales Price (USD/Pcs)
Table 2016 Global Live Attenuated Vaccine Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Live Attenuated Vaccine 2012-2017E
Figure North America 2012-2017E Live Attenuated Vaccine Sales Price (USD/Pcs)
Figure North America 2016 Live Attenuated Vaccine Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Live Attenuated Vaccine 2012-2017E
Figure China 2012-2017E Live Attenuated Vaccine Sales Price (USD/Pcs)
Figure China 2016 Live Attenuated Vaccine Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Live Attenuated Vaccine 2012-2017E
Figure Europe 2012-2017E Live Attenuated Vaccine Sales Price (USD/Pcs)
Figure Europe 2016 Live Attenuated Vaccine Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Live Attenuated Vaccine 2012-2017E
Figure Southeast Asia 2012-2017E Live Attenuated Vaccine Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Live Attenuated Vaccine Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Live Attenuated Vaccine 2012-2017E
Figure Japan 2012-2017E Live Attenuated Vaccine Sales Price (USD/Pcs)
Figure Japan 2016 Live Attenuated Vaccine Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Live Attenuated Vaccine 2012-2017E
Figure India 2012-2017E Live Attenuated Vaccine Sales Price (USD/Pcs)
Figure India 2016 Live Attenuated Vaccine Sales Market Share
Table Global 2012-2017E Live Attenuated Vaccine Sales (K Pcs) by Type
Table Different Types Live Attenuated Vaccine Product Interview Price
Table Global 2012-2017E Live Attenuated Vaccine Sales (K Pcs) by Application
Table Different Application Live Attenuated Vaccine Product Interview Price
Table Astellas Pharma (Japan) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Astellas Pharma (Japan) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Astellas Pharma (Japan) Live Attenuated Vaccine Business Region Distribution
Table CSL Limited (Australia) Information List
Table Product A Overview
Table Product B Overview
Table 2016 CSL Limited (Australia) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 CSL Limited (Australia) Live Attenuated Vaccine Business Region Distribution
Table Emergent BioSolutions (U.S.) Information List
Table Product A Overview
Table Product B Overview
Table 2015 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Business Region Distribution
Table GlaxoSmithKline (U.K.) Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Business Region Distribution
Table Johnson & Johnson (U.S.) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson (U.S.) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Johnson & Johnson (U.S.) Live Attenuated Vaccine Business Region Distribution
Table MedImmune (U.S.) Information List
Table Product A Overview
Table Product B Overview
Table 2016 MedImmune (U.S.) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 MedImmune (U.S.) Live Attenuated Vaccine Business Region Distribution
Table Merck & Co (U.S.) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co (U.S.) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck & Co (U.S.) Live Attenuated Vaccine Business Region Distribution
Table Pfizer (U.S.) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer (U.S.) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Pfizer (U.S.) Live Attenuated Vaccine Business Region Distribution
Table Sanofi Pasteur (France) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Pasteur (France) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Sanofi Pasteur (France) Live Attenuated Vaccine Business Region Distribution
Table Serum Institute of India Pvt (India) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Serum Institute of India Pvt (India) Live Attenuated Vaccine Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Serum Institute of India Pvt (India) Live Attenuated Vaccine Business Region Distribution
Figure Global 2017-2022 Live Attenuated Vaccine Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Live Attenuated Vaccine Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Live Attenuated Vaccine Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Live Attenuated Vaccine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Live Attenuated Vaccine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Live Attenuated Vaccine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Live Attenuated Vaccine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Live Attenuated Vaccine Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Live Attenuated Vaccine Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Live Attenuated Vaccine by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Live Attenuated Vaccine by Application 2017-2022
Table Traders or Distributors with Contact Information of Live Attenuated Vaccine by Region